Skip to main content
. 2017 May 18;8(27):44669–44681. doi: 10.18632/oncotarget.17965

Table 2. Hazard ratio of BRSK2 in IMPN+PDAC patients.

Variables Hazard ratio 95% CI
BRSK2 in tumor 1.390 0.794–2.435
pAkt substrate in tumor 1.499 0.579–3.878
MV fraction 0.732 0.437–1.225
MVD 0.740 0.433–1.236
Tumor stage 2.087 1.197–3.640
Regional lymph status 1.414 0.995–2.010
Tumor size 1.362 0.929–1.998
Nerve invasion 2.102 1.247–3.544
Vascular invasion 1.830 1.111–3.014